FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 251 through 277 of 277

- SIC # 2830

Ticker Exchange Company Financial Reports SIC #
TIL Nasdaq Instil Bio, Inc. 2830
TRVI Nasdaq Trevi Therapeutics, Inc. 2830
TSHA Nasdaq Taysha Gene Therapies, Inc. 2830
TVGN Nasdaq Tevogen Bio Holdings Inc. 2830
TVTX Nasdaq Travere Therapeutics, Inc. 2830
UG Nasdaq United-Guardian, Inc. 2830
UNCY Nasdaq Unicycive Therapeutics, Inc. 2830
UPC Nasdaq Universe Pharmaceuticals INC 2830
UPXI Nasdaq Upexi, Inc. 2830
URGN Nasdaq UroGen Pharma Ltd. 2830
VCEL Nasdaq Vericel Corporation 2830
VERU Nasdaq Veru Inc. 2830
VKTX Nasdaq Viking Therapeutics, Inc. 2830
VOR Nasdaq Vor Biopharma Inc. 2830
VRCA Nasdaq Verrica Pharmaceuticals Inc. 2830
VRNO Over the counter Verano Holdings Corp. 2830
VSTM Nasdaq Verastem, Inc. 2830
VTYX Nasdaq Ventyx Biosciences, Inc. 2830
VYNE Nasdaq VYNE Therapeutics Inc. 2830
WALD Nasdaq Waldencast plc 2830
WHWK Nasdaq Whitehawk Therapeutics, Inc. 2830
XBIO Nasdaq Xenetic Biosciences, Inc. 2830
XOMA Nasdaq XOMA Royalty Corporation 2830
XRTX Nasdaq XORTX Therapeutics Inc. 2830
ZLAB Nasdaq Zai Lab Limited 2830
ZTS New York Zoetis Inc. 2830
ZYBT Nasdaq Zhengye Biotechnology Holding Limited 2830
Results 250 through 277 of 277